Atlas Cycles Q1FY27 net loss widens to ₹192 lakh on revenue drop
Atlas Cycles (Haryana) Ltd reported a Q1FY27 net loss of ₹192.02 lakh, widening from ₹158.38 lakh in Q1FY26, as revenue fell 22.5% to ₹153.57 lakh. Statutory auditors flagged unprovided interest liabilities and creditor suits. The Board also extended the deadline for a ₹60 crore land sale in Sonepat to December 31, 2026.

*this image is generated using AI for illustrative purposes only.
Atlas Cycles (Haryana) reported a widened net loss of ₹192.02 lakh for the quarter ended June 30, 2026, compared to a ₹158.38 lakh loss in the corresponding quarter of the previous fiscal year. The company’s revenue from operations declined to ₹153.57 lakh, down from ₹198.27 lakh in Q1FY26. The Board of Directors approved the unaudited financial results on August 12, 2026, alongside a significant disclosure regarding the sale of its Sonepat land asset.
The statutory auditors, Dinesh Nangru & Co., issued a review report with a modified conclusion under Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The audit firm highlighted that the company has not provided for interest on overdue outstanding payments to creditors, including Micro, Small and Medium Enterprises (MSMEs), nor for suits filed by creditors. Additionally, the company defaulted on an Inter-Corporate Loan repayment and failed to provide for the associated interest liability, resulting in an understatement of losses by ₹24.75 lakh.
Financial Performance
The company’s total income stood at ₹153.57 lakh, with no other income reported for the quarter, contrasting with ₹7.92 lakh in other income during Q4FY26. Total expenses rose to ₹345.59 lakh from ₹372.09 lakh in Q1FY25 but increased significantly from ₹409.49 lakh in the immediately preceding quarter. Employee benefit expenses were ₹52.66 lakh, while depreciation and amortization remained flat at ₹43.98 lakh compared to the same quarter last year.
| Particulars | Q1FY27 (₹ Lakh) | Q4FY26 (₹ Lakh) | Q1FY26 (₹ Lakh) |
|---|---|---|---|
| Revenue from operations | 153.57 | 145.27 | 198.27 |
| Other income | - | 7.92 | 15.44 |
| Total income | 153.57 | 153.19 | 213.71 |
| Total expenses | 345.59 | 409.49 | 372.09 |
| Net profit / (loss) | -192.02 | -256.30 | -158.38 |
| EPS (Basic/Diluted) | -2.95 | -3.94 | -2.44 |
Land Sale Extension
In a separate development, the Board approved a request from the buyer to extend the deadline for executing the sale deed of 20 acres of land situated in Sonepat, Haryana. The new deadline is December 31, 2026. Under the Agreement to Sell dated December 7, 2024, the company has received an advance of ₹45.00 crore. The buyer has undertaken to pay another ₹15.00 crore by October 30, 2026.
What the Numbers Show
The financial data reveals a concerning divergence between operational scale and cost structure. While revenue from operations dropped by approximately 22.5% year-on-year, employee benefit expenses remained nearly static at ₹52.66 lakh (versus ₹54.63 lakh in Q1FY26), suggesting limited flexibility in fixed cost reduction despite lower sales volumes. Furthermore, the absence of other income in Q1FY27, compared to ₹15.44 lakh in the prior year, eliminated a minor offset to operating losses, exacerbating the net deficit. The auditor’s qualification regarding unprovided interest liabilities indicates potential future cash outflows that are not yet reflected in the current loss figure.
Historical Stock Returns for Atlas Cycle (Haryana)
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.41% | +0.28% | -1.28% | +15.44% | -21.63% | 0.0% |
How will the potential cash inflow from the Sonepat land sale impact Atlas Cycles' ability to settle overdue MSME payments and clear the auditor-identified interest liabilities?
What specific operational restructuring measures is the company planning to implement to reduce fixed employee costs in response to the 22.5% year-on-year revenue decline?
Could the statutory auditor's modified conclusion regarding unprovided liabilities trigger regulatory scrutiny or affect the company's listing status on stock exchanges?


































